Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.35USD
12 Dec 2017
Change (% chg)

$0.12 (+0.82%)
Prev Close
$15.23
Open
$15.30
Day's High
$15.45
Day's Low
$14.90
Volume
36,079
Avg. Vol
52,890
52-wk High
$15.95
52-wk Low
$5.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.67 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.17 0.30 0.00 2.60
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 4 1.10 1.20 0.90 4.14
Year Ending Dec-18 4 18.10 32.50 0.00 18.23
Earnings (per share)
Quarter Ending Dec-17 3 -0.67 -0.63 -0.70 -0.44
Quarter Ending Mar-18 3 -0.60 -0.56 -0.63 --
Year Ending Dec-17 3 -2.68 -2.64 -2.71 -2.03
Year Ending Dec-18 4 -1.49 -0.45 -2.28 -1.55

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.17 0.30 0.13 79.36
Quarter Ending Jun-17 0.20 0.30 0.10 49.65
Quarter Ending Mar-17 0.15 0.30 0.15 102.85
Quarter Ending Dec-16 0.23 0.30 0.07 29.50
Quarter Ending Sep-16 0.18 0.30 0.12 70.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.17 0.17 0.17 0.17 2.60
Quarter Ending Mar-18 0.00 0.00 0.15 0.15 --
Year Ending Dec-17 1.10 1.10 1.10 0.93 4.14
Year Ending Dec-18 18.10 18.10 18.10 35.59 18.23

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings